Tous Actualités
Suivre
Abonner Prionics AG

Prionics AG

Prionics acquires Pfizer Animal Health's diagnostic products: Promising products for the Swiss success company

Zurich (ots)

Prionics AG, the world leader in prion diagnostics
and Pfizer Animal Health, the world's leading animal health company,
agreed today that Prionics will acquire Pfizer Animal Health's
diagnostic products. Terms were not disclosed.
The product line includes tests for the detection of Bovine
tuberculosis (Bovigam®) and Paratuberculosis (Parachek®) in animals
raised as a food source. Both diseases cause major economic damage to
the farm industry and also have implications to human health.
Bovigam® and Parachek® are among the leading products in their
field with significant shares in existing markets and an attractive
potential for the development of new markets. "With this expansion of
our product portfolio, we are confident that we're well positioned to
further grow sustainably in the farm animal diagnostics business",
says Ernst Zollinger, Head of Marketing & Sales at Prionics.
Prionics will fully integrate the diagnostic tests into its
product portfolio through a one year transition phase to ensure a
smooth changeover. "We are confident, that our new clients will
profit from Prionics' specialized customer service. We will contact
these customers directly to inform them about the planned steps",
explains Zollinger. "Moreover, we intend to use our innovative
development know-how to further improve the two tests in order to
offer our clients even better solutions."
Tuberculosis and Paratuberculosis
Bovine tuberculosis and Paratuberculosis are major farm animal
diseases that cause severe economic damage in breeding stock, milk
and meat producing animals worldwide with severe implications to
human health. Diagnostic tests for Bovine tuberculosis and
Paratuberculosis can help to reduce the risk of infection in humans
as well as contribute to targeted eradication and control of these
diseases.
Bovine tuberculosis (TB) is an infectious disease that is caused
by the bacteria Mycobacterium bovis (M. bovis). Bovine TB primarily
affects cattle, however, other animals may become infected. Disease
due to  M. bovis in animals most often occurs in the lungs but may
also occur in the intestines and other parts of the body. M. bovis is
transmitted to humans primarily through consumption of raw milk or
dairy products but can also be transmitted through the respiratory
route.
Paratuberculosis leads to Johne's Disease in cattle, goat and wild
animals and has been implicated as a causal agent for Crohn's Disease
in humans - a chronic inflammatory bowel disease.
About Prionics
The world market leader for rapid prion testing was founded in
1997 as a spin-off from the University of Zurich. Prionics carries
out research and development in diagnostics for prion diseases (such
as BSE) and other zoonotic diseases. The recipient of the Swiss
Economic Award 2002 as "Company of the year" and winner of the
European Biotech Award 2004 for Excellence in Biotech Business is
driving its business through a combination of outstanding research,
high-quality products and new marketing concepts.
For more information please visit www.prionics.com

Contact:

Stephanie Musshafen
Director of Corporate Communications
Tel. +41/44/200'20'95
E-Mail: press.relations@prionics.ch

Plus de actualités: Prionics AG
Plus de actualités: Prionics AG
  • 22.09.2004 – 14:14

    European Biotech Award goes to Swiss-based Prionics

    Zurich (ots) - The Swiss-based company Prionics AG has won the most highly acclaimed European Biotech Award, the European Biotechnica Award for Excellence in Biotech Business. The award was handed over yesterday at the Biotechnica Business Forum in Berlin by the German Federal Minister of Economic Affairs, Wolfgang Clement. The international jury awarded the Biotech prize for Prionics' excellent track record both ...